BioCentury | Mar 9, 2018
Emerging Company Profile

Reviving lixivaptan

...ADPKD. Lixivaptan had been shelved following a complete response letter (CRL) for hyponatremia in 2012. Cornerstone Therapeutics Inc....
BioCentury | Sep 8, 2014
Finance

Chiesi expands rare disease universe

...diseases as well as specialty care. Earlier this year, it acquired U.S. rare disease partner Cornerstone Therapeutics Inc....
BioCentury | Feb 10, 2014
Company News

Chiesi, Cornerstone Therapeutics deal

...cash, or $265.2 million (see BioCentury, Sept. 23, 2013). Chiesi Farmaceutici S.p.A. , Parma, Italy Cornerstone Therapeutics Inc....
BioCentury | Nov 25, 2013
Company News

Cornerstone Therapeutics sales and marketing update

...is slated to close in 1Q14 (see BioCentury, Nov. 19, 2012 & Sept. 23, 2013). Cornerstone Therapeutics Inc....
BioCentury | Nov 11, 2013
Finance

OrbiMed's high five

...SG&A expenses to $202.2M in the quarter. Percent changes for revenue figures assume constant currency. Cornerstone Therapeutics Inc....
BioCentury | Sep 30, 2013
Company News

InterMune management update

...as EVP, general counsel and corporate secretary, formerly EVP, general counsel and corporate secretary at Cornerstone Therapeutics Inc. WIR...
BioCentury | Sep 23, 2013
Finance

Highlights of weekly biotech stock moves

...market rumors. Its CO-1686 is in Phase I/II testing for non-small cell lung cancer (NSCLC). Cornerstone Therapeutics Inc....
BioCentury | Sep 23, 2013
Company News

Chiesi, Cornerstone Therapeutics deal

...and Cornerstone had 2012 net revenues of $116.1 million. Chiesi Farmaceutici S.p.A. , Parma, Italy Cornerstone Therapeutics Inc....
BioCentury | Sep 17, 2013
Company News

Chiesi to acquire Cornerstone

...Chiesi Farmaceutici S.p.A. (Parma, Italy) will acquire the 42% of shares of partner Cornerstone Therapeutics Inc. (NASDAQ:CRTX) it...
BioCentury | Aug 5, 2013
Company News

Cornerstone Therapeutics, Exela PharmSci Inc. cardiovascular news

...of EKR Therapeutics Inc. last June (see BioCentury, July 2, 2012 & June 17, 2013). Cornerstone Therapeutics Inc....
Items per page:
1 - 10 of 224
BioCentury | Mar 9, 2018
Emerging Company Profile

Reviving lixivaptan

...ADPKD. Lixivaptan had been shelved following a complete response letter (CRL) for hyponatremia in 2012. Cornerstone Therapeutics Inc....
BioCentury | Sep 8, 2014
Finance

Chiesi expands rare disease universe

...diseases as well as specialty care. Earlier this year, it acquired U.S. rare disease partner Cornerstone Therapeutics Inc....
BioCentury | Feb 10, 2014
Company News

Chiesi, Cornerstone Therapeutics deal

...cash, or $265.2 million (see BioCentury, Sept. 23, 2013). Chiesi Farmaceutici S.p.A. , Parma, Italy Cornerstone Therapeutics Inc....
BioCentury | Nov 25, 2013
Company News

Cornerstone Therapeutics sales and marketing update

...is slated to close in 1Q14 (see BioCentury, Nov. 19, 2012 & Sept. 23, 2013). Cornerstone Therapeutics Inc....
BioCentury | Nov 11, 2013
Finance

OrbiMed's high five

...SG&A expenses to $202.2M in the quarter. Percent changes for revenue figures assume constant currency. Cornerstone Therapeutics Inc....
BioCentury | Sep 30, 2013
Company News

InterMune management update

...as EVP, general counsel and corporate secretary, formerly EVP, general counsel and corporate secretary at Cornerstone Therapeutics Inc. WIR...
BioCentury | Sep 23, 2013
Finance

Highlights of weekly biotech stock moves

...market rumors. Its CO-1686 is in Phase I/II testing for non-small cell lung cancer (NSCLC). Cornerstone Therapeutics Inc....
BioCentury | Sep 23, 2013
Company News

Chiesi, Cornerstone Therapeutics deal

...and Cornerstone had 2012 net revenues of $116.1 million. Chiesi Farmaceutici S.p.A. , Parma, Italy Cornerstone Therapeutics Inc....
BioCentury | Sep 17, 2013
Company News

Chiesi to acquire Cornerstone

...Chiesi Farmaceutici S.p.A. (Parma, Italy) will acquire the 42% of shares of partner Cornerstone Therapeutics Inc. (NASDAQ:CRTX) it...
BioCentury | Aug 5, 2013
Company News

Cornerstone Therapeutics, Exela PharmSci Inc. cardiovascular news

...of EKR Therapeutics Inc. last June (see BioCentury, July 2, 2012 & June 17, 2013). Cornerstone Therapeutics Inc....
Items per page:
1 - 10 of 224